Anti-PDCD4 antibody (ab63359)

Overview

• Product nameAnti-PDCD4 antibodySee all PDCD4 primary antibodies ...
• Description
  Rabbit polyclonal to PDCD4
• Tested applicationsWB, ELISA, ICC/IF more details
• Species reactivity
  Reacts with: Human
  Predicted to work with: Mouse, Rat
• Immunogen

  Synthetic non-phosphopeptide derived from human PDCD4 around the phosphorylation site of serine 457

• Positive control293 cells; HeLa cells.

Properties

• FormLiquid
• Storage instructionsStore at -20°C. Stable for 12 months at -20°C
• Storage bufferPreservative: 0.02% Sodium Azide
  Constituents: 50% Glycerol, PBS, 150mM Sodium chloride, pH 7.4
• Concentration information loading...
• PurityImmunogen affinity purified
• Clonality Polyclonal
• IsotypeIgG
• Research Areas
  • Cancer
  • Invasion/microenvironment
  • Apoptosis
  • Other

  • Epigenetics and Nuclear Signaling
  • Transcription
  • Other factors

  • Cell Biology
  • Apoptosis
  • Nucleus
  • Other

  • Cell Biology
  • Cell Cycle
  • Cell Cycle Inhibitors
  • Other

Applications

Target

• FunctionInhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA.
• Tissue specificityUp-regulated in proliferative cells. Highly expressed in epithelial cells of the mammary gland. Reduced expression in lung cancer and colon carcinoma.
• Sequence similaritiesBelongs to the PDCD4 family.
  Contains 2 MI domains.
• DomainBinds EIF4A1 via both MI domains.
• Post-translational
  modificationsPolyubiquitinated, leading to its proteasomal degradation. Rapidly degraded in response to mitogens. Phosphorylation of the phosphodegron promotes interaction with BTRC and proteasomal degradation.
• Cellular localizationNucleus. Cytoplasm. Shuttles between the nucleus and cytoplasm. Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457. Exported from the nucleus in the absence of serum.

Target information above from: UniProt accession Q53EL6 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010) .

Information by UniProt
• Database links
  • Entrez Gene: 27250 Human
  • Entrez Gene: 18569 Mouse
  • Entrez Gene: 64031 Rat
  • Omim: 608610 Human
  • SwissProt: Q53EL6 Human
  • SwissProt: Q61823 Mouse
  • SwissProt: Q9JID1 Rat
  • Unigene: 711490 Human

  • Unigene: 1605 Mouse
  • Unigene: 375091 Mouse
  • Unigene: 206228 Rat

  see all

• Alternative names
  Death up-regulated gene protein antibodyDug antibodyH731 antibody

  Ma3 antibodyMGC33046 antibodyMGC33047 antibodyNeoplastic transformation inhibitor antibodyNeoplastic transformation inhibitor protein antibodyNuclear antigen H731 antibodyNuclear antigen H731 like antibodyNuclear antigen H731 like protein antibodyNuclear antigen H731-like antibodyPDCD 4 antibodyPdcd4 antibodyPDCD4_HUMAN antibodyProgrammed cell death 4 antibodyprogrammed cell death 4 (neoplastic transformation inhibitor) antibodyProgrammed cell death protein 4 antibodyProtein 197/15a antibodyProtein MA-3 antibodyRP11 348N5.4 antibodyTis antibodyTopoisomerase-inhibitor suppressed protein antibody

  see all

Anti-PDCD4 antibody images

• 

  Western blot - PDCD4 antibody (ab63359)
  All lanes : Anti-PDCD4 antibody (ab63359) at 1/500 dilution
  
  Lane 1 : extracts from 293 cells
  Lane 2 : extracts from 293 cells, with immunizing peptide
  
  
  Predicted band size : 52 kDa
  Observed band size : 52 kDa
  Additional bands at : 56 kDa. We are unsure as to the identity of these extra bands.
• 

  Immunocytochemistry/ Immunofluorescence - PDCD4 antibody (ab63359)
  Immunofluorescence analysis of PDCD4 expression in HeLa cells, using 1/500 ab63359. Left: untreated cells. Right: cells treated with immunising peptide.